CIVIS Media Prize 2022 competition now open! / Closing date: 19 January 2022
29.11.2021 11:12:00 CET | news aktuell GmbH | Pressemelding
Cologne, 29.11.2021
The CIVIS Awards are presented in four fields and in various categories:
- VIDEO AWARD: Non-fiction programmes, fiction programmes and social media formats (moving images)
- AUDIO AWARD: Short programmes of up to six minutes, long programmes over six minutes and podcasts
- YOUNG C. AWARD (films, age restriction applies)
- CINEMA AWARD (audience award)
The CIVIS TOP AWARD is an additional prize honouring the best production of the year in the AUDIO, VIDEO and YOUNG C. categories. No direct candidatures can be entered for the CIVIS TOP AWARD.
The total prize money is € 27,000.
Click here to register: https://registration.civismedia.eu/
The CIVIS Media Prize is sponsored by ARD, represented by WDR, together with the Freudenberg Foundation. ORF, SRG SSR, RTV Slovenia, ARTE, 3sat, phoenix, Deutsche Welle, Deutschlandradio and EBU are media partners. The Federal Government Commissioner for Integration, WDR mediagroup, the German Producers Alliance – Film & Television, VFF Verwertungsgesellschaft der Film- und Fernsehproduzenten and the European Union Agency for Fundamental Rights (FRA) are cooperation partners.
The non-profit CIVIS Media Foundation for Integration and Cultural Diversity in Cologne is responsible for organising the competition, jury meetings and award ceremony.
The European CIVIS Media Prize aims to encourage media professionals to deal with topics of migration, integration, cultural diversity and social cohesion in a creative, constructive and, where necessary, (self) critical way.
Follow CIVIS on Facebook | Instagram | Twitter | YouTube
#civis2022
Here are the conditions of participation 2022
Press contact
CIVIS Medienstiftung
für Integration und kulturelle Vielfalt in Europa
Ferdos Forudastan
Telefon: +49 (0)221 277 5870
E-Mail: info@civismedia.eu
www.civismedia.eu
Om news aktuell GmbH
news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.
Følg pressemeldinger fra news aktuell GmbH
Registrer deg med din e-postadresse under for å få de nyeste sakene fra news aktuell GmbH på e-post fortløpende. Du kan melde deg av når som helst.
Siste pressemeldinger fra news aktuell GmbH
Grünenthal takes full ownership of Grünenthal Meds, the joint venture established with Kyowa Kirin for its established medicines brands2.3.2026 10:39:09 CET | Press release
Grünenthal acquired Kyowa Kirin International’s 49% stake in ‘Grünenthal Meds’, a joint venture formed in 2023 to market the established medicines portfolio from Kyowa Kirin International. Through this acquisition, Grünenthal assumes the sole responsibility of a portfolio comprising 12 brands across six therapeutic areas and >60 markets.
Valle Venia presents new song by LPS feat. Lara: Where will it take me27.2.2026 10:15:00 CET | Press release
The song describes the challenge of trusting the flow, relying on oneself, following one's own values with confidence.
Vyoma awarded ESA data procurement contract for space-based data on small space debris24.2.2026 10:53:34 CET | Press release
(Munich, February 24th, 2026) Vyoma, a Munich-based company providing Space Domain Awareness (SDA) capabilities, has been selected as the winner of the ESA tender on ”Data Procurement for Space-Based Statistical Data on Small Space Debris Phase 1”, funded via ESA‘s Space Safety Programme (S2P). ESA’s Meteoroid And Space debris Terrestrial Environment Reference (MASTER) model provides a description of the space environment around Earth, supporting satellite designers, operators and others with risk assessments. Currently, there exists a significant temporal and spatial knowledge gap for observations of space debris with sizes smaller than the detection limit of ground-based sensors. Vyoma's Flamingo-1 satellite is ideally positioned to generate the image data ESA is seeking. Flying “in-situ” at an altitude of 510 km, Flamingo-1's instrument can monitor large volumes of space at once. This sensor detects objects at long and short distances and captures small and fast objects reliably, im
Medi-Globe Launches mAI Companion® — the World’s First Real Time AI Assistant for Pancreatic EUS, Co Developed with IHU Strasbourg —Now MDR CE Marked and Available for Clinical Use in Europe24.2.2026 10:00:00 CET | Press release
Rohrdorf (Achenmühle), Germany — February 24, 2026 — Medi-Globe today announced the launch of mAI Companion®, a real-time medical AI solution designed to assist physicians in detecting pancreatic lesions during endoscopic ultrasound (EUS) — addressing one of the deadliest and most difficult-to-detect cancers, where earlier identification can dramatically change patient outcomes.
Grünenthal licenses exclusive Australian rights to Qutenza® to Clinect24.2.2026 08:43:52 CET | Press release
Aachen, Germany & Victoria, Australia, 24 February 2026 – Grünenthal, a global leader in pain management and related diseases, and Clinect Pty Ltd ("Clinect"), an Australian based company focussed on supporting access to unique products, announced today that they have entered into a definitive agreement whereby Clinect will have the exclusive Australian rights to Qutenza®, a topical, non-systemic, non-opioid patch indicated for the management of peripheral neuropathic pain. Under the agreement, Clinect will be responsible for obtaining marketing authorisation for Qutenza® in Australia and, upon approval, marketing and distributing the product in Australia.
I vårt presserom finner du alle våre siste pressemeldinger, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.
Besøk vårt presserom